Wed, 12th Mar 2014 17:23
LONDON (Alliance News) Akers Biosciences Wednesday said Chief Executive Thomas Nicolette will step down from the board and leave the company on March 28.
Nicolette, who has been at the helm since 2008, will be replaced by Executive Chairman Raymond Akers.
The stock closed at 340.00 pence Wednesday, down 15.00 pence or 4.2%.
By Anthony Tshibangu; anthonytshibangu@alliancenews.com; @AnthonyAllNews
Copyright © 2014 Alliance News Limited. All Rights Reserved.
(Sharecast News) - Akers Biosciences appointed Howard Yeaton as chief executive on Monday as the company reached a settlement in its legal dispute wit...
(Sharecast News) - Akers Biosciences' losses burgeoned as second-quarter revenues were cut in half after softer sales of its flagship Heparin rapid as...
LONDON (Alliance News) - Akers Biosciences Inc on Tuesday said revenue grew in 2017, but its loss widened due to increased costs across the business.T...
LONDON (Alliance News) - Akers Biosciences Inc, a developer of health screening and testing products, said Friday that it has netted USD48,750 from wa...
(ShareCast News) - Akers Biosciences, a developer of rapid health information technologies, has been granted a US patent for its wellness disposable m...
